John Hamer - Net Worth and Insider Trading

John Hamer Net Worth

The estimated net worth of John Hamer is at least $39 Million dollars as of 2024-11-08. John Hamer is the Director of AbCellera Biologics Inc and owns about 14,734,623 shares of AbCellera Biologics Inc (ABCL) stock worth over $39 Million. Details can be seen in John Hamer's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Hamer has not made any transactions after 2021-09-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of John Hamer

To

John Hamer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Hamer owns 1 companies in total, including AbCellera Biologics Inc (ABCL) .

Click here to see the complete history of John Hamer’s form 4 insider trades.

Insider Ownership Summary of John Hamer

Ticker Comapny Transaction Date Type of Owner
ABCL AbCellera Biologics Inc 2021-09-01 director & 10 percent owner

John Hamer Latest Holdings Summary

John Hamer currently owns a total of 1 stock. John Hamer owns 14,734,623 shares of AbCellera Biologics Inc (ABCL) as of September 1, 2021, with a value of $39 Million.

Latest Holdings of John Hamer

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABCL AbCellera Biologics Inc 2021-09-01 14,734,623 2.66 39,120,424

Holding Weightings of John Hamer


John Hamer Form 4 Trading Tracker

According to the SEC Form 4 filings, John Hamer has made a total of 1 transactions in AbCellera Biologics Inc (ABCL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in AbCellera Biologics Inc is the sale of 300,000 shares on September 1, 2021, which brought John Hamer around $5 Million.

Insider Trading History of John Hamer

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John Hamer Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John Hamer Ownership Network

Ownership Network List of John Hamer

No Data

Ownership Network Relation of John Hamer

Insider Network Chart

John Hamer Owned Company Details

What does AbCellera Biologics Inc do?

Who are the key executives at AbCellera Biologics Inc?

John Hamer is the director & 10 percent owner of AbCellera Biologics Inc. Other key executives at AbCellera Biologics Inc include 10 percent owner Thermopylae Holdings Ltd. , director & Chief Operating Officer Veronique Lecault , and Chief Financial Officer Andrew Booth .

AbCellera Biologics Inc (ABCL) Insider Trades Summary

Over the past 18 months, John Hamer made no insider transaction in AbCellera Biologics Inc (ABCL). Other recent insider transactions involving AbCellera Biologics Inc (ABCL) include a net purchase of 436,516 shares made by Thermopylae Holdings Ltd. , a net purchase of 50,000 shares made by Michael R Hayden , and a net purchase of 30,000 shares made by John S. Montalbano .

In summary, during the past 3 months, insiders sold 0 shares of AbCellera Biologics Inc (ABCL) in total and bought 283,516 shares, with a net purchase of 283,516 shares. During the past 18 months, 0 shares of AbCellera Biologics Inc (ABCL) were sold and 551,016 shares were bought by its insiders, resulting in a net purchase of 551,016 shares.

AbCellera Biologics Inc (ABCL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AbCellera Biologics Inc Insider Transactions

No Available Data

John Hamer Mailing Address

Above is the net worth, insider trading, and ownership report for John Hamer. You might contact John Hamer via mailing address: Po Box 14528, Research Triangle Park Nc 27709-4528.